David Jarjoura

Summary

Affiliation: Northeastern Ohio Universities College of Medicine
Country: USA

Publications

  1. ncbi A comparison of normalization techniques for microRNA microarray data
    Youlan Rao
    The Ohio State University, USA
    Stat Appl Genet Mol Biol 7:Article22. 2008
  2. ncbi Crossing controls to treatment in repeated-measures trials
    David Jarjoura
    Office of Biostatistics, College of Medicine, Northeastern Ohio Universities, PO Box 95, Rootstown, OH 44272 0095, USA
    Control Clin Trials 24:306-23. 2003
  3. ncbi Inferences from aggregated data
    David Jarjoura
    Office of Biostatistics, Northeastern Ohio Universities College of Medicine, Rootstown, OH, USA
    Acad Emerg Med 10:881-2. 2003
  4. ncbi Effectiveness of screening and treatment for depression in ambulatory indigent patients
    David Jarjoura
    Community Health Sciences, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44272 0095, USA
    J Gen Intern Med 19:78-84. 2004
  5. ncbi Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta
    Donna King
    Department of Biochemistry and Molecular Pathology, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44272, USA
    J Bone Miner Res 20:987-93. 2005
  6. ncbi The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
    David M Lucas
    Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
    Blood 113:4656-66. 2009
  7. ncbi Transtheoretical model-chronic disease care for obesity in primary care: a randomized trial
    Everett Logue
    Department of Family Practice, Summa Health System, 525 East Market Street, Suite 290, Akron, OH 44309 2090, USA
    Obes Res 13:917-27. 2005
  8. ncbi Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
    Ergun Kocak
    Division of Cancer Immunology, Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA
    Cancer Res 66:7276-84. 2006
  9. ncbi The AD-LIFE trial: working to integrate medical and psychosocial care management models
    Kathy Wright
    Summa Center for Senior Health and Care Coordination Program, Summa Health System, 41 Arch Street, Akron, OH 44304, USA
    Home Healthc Nurse 25:308-14. 2007
  10. ncbi The influence of controllable lifestyle and sex on the specialty choices of graduating U.S. medical students, 1996-2003
    E Ray Dorsey
    University of Rochester, School of Medicine and Dentistry, 1351 Mt Hope Avenue, Suite 223, Rochester, NY 14620, USA
    Acad Med 80:791-6. 2005

Collaborators

  • Jason C Hsu
  • Donna King
  • Xiaoli Zhang
  • Everett Logue
  • Youlan Rao
  • David M Lucas
  • Kathy Wright
  • Ergun Kocak
  • E Ray Dorsey
  • Melanie E Davis
  • John C Byrd
  • Darlene M Rozewski
  • Nyla A Heerema
  • Virginia M Goettl
  • Jungook D Shin
  • Thomas S Lin
  • Melissa A Vargo
  • Amy Lehman
  • A Douglas Kinghorn
  • Ryan B Edwards
  • Michael R Grever
  • Amy J Johnson
  • Gerard Lozanski
  • Derek A West
  • Bao Ning Su
  • David J Newman
  • Susan Hazelett
  • Kyle Allen
  • Huiming Zhang
  • Katie R Exten
  • Kenneth Lute
  • Pan Zheng
  • Xing Chang
  • Amy M Lehman
  • Yang Liu
  • Kenneth F May
  • Shahab F Abdessalam
  • Gregory W Rutecki

Detail Information

Publications10

  1. ncbi A comparison of normalization techniques for microRNA microarray data
    Youlan Rao
    The Ohio State University, USA
    Stat Appl Genet Mol Biol 7:Article22. 2008
    ..Furthermore, we show that quantile normalization does not achieve these results by compression of scale...
  2. ncbi Crossing controls to treatment in repeated-measures trials
    David Jarjoura
    Office of Biostatistics, College of Medicine, Northeastern Ohio Universities, PO Box 95, Rootstown, OH 44272 0095, USA
    Control Clin Trials 24:306-23. 2003
    ..This sensitivity to model means that the practical and statistical advantages of crossing controls over to treatment only sometimes outweigh those of the traditional continued-control design...
  3. ncbi Inferences from aggregated data
    David Jarjoura
    Office of Biostatistics, Northeastern Ohio Universities College of Medicine, Rootstown, OH, USA
    Acad Emerg Med 10:881-2. 2003
  4. ncbi Effectiveness of screening and treatment for depression in ambulatory indigent patients
    David Jarjoura
    Community Health Sciences, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44272 0095, USA
    J Gen Intern Med 19:78-84. 2004
    ..To determine the effectiveness of screening and treatment for depression among ambulatory indigent patients visiting resident physicians...
  5. ncbi Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta
    Donna King
    Department of Biochemistry and Molecular Pathology, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio 44272, USA
    J Bone Miner Res 20:987-93. 2005
    ..Biomechanical testing showed improvements to structural and material properties in the femur midshaft, supporting expanded testing of growth hormone therapy in children with OI...
  6. ncbi The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
    David M Lucas
    Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
    Blood 113:4656-66. 2009
    ..These data indicate silvestrol has efficacy against B cells in vitro and in vivo and identify translational inhibition as a potential therapeutic target in B-cell leukemias...
  7. ncbi Transtheoretical model-chronic disease care for obesity in primary care: a randomized trial
    Everett Logue
    Department of Family Practice, Summa Health System, 525 East Market Street, Suite 290, Akron, OH 44309 2090, USA
    Obes Res 13:917-27. 2005
    ..Weight change was the primary outcome...
  8. ncbi Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
    Ergun Kocak
    Division of Cancer Immunology, Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA
    Cancer Res 66:7276-84. 2006
    ..The reduction of autoimmune effects correlates with an increased function of regulatory T cells. Our results suggest a novel approach to simultaneously enhance cancer immunity and reduce autoimmunity...
  9. ncbi The AD-LIFE trial: working to integrate medical and psychosocial care management models
    Kathy Wright
    Summa Center for Senior Health and Care Coordination Program, Summa Health System, 41 Arch Street, Akron, OH 44304, USA
    Home Healthc Nurse 25:308-14. 2007
    ..A case study of a patient participant in the AD-LIFE study is presented. The case illustrates the positive effects of the intervention on biopsychosocial outcomes...
  10. ncbi The influence of controllable lifestyle and sex on the specialty choices of graduating U.S. medical students, 1996-2003
    E Ray Dorsey
    University of Rochester, School of Medicine and Dentistry, 1351 Mt Hope Avenue, Suite 223, Rochester, NY 14620, USA
    Acad Med 80:791-6. 2005
    ..To determine whether the preferences of female medical students are sufficient to explain the recent trend of U.S. medical students choosing specialties with controllable lifestyles...